The evolution of gout (an old disease of lifestyle)
Background: Few diseases that confront the 21st century clinician have documented history which dates back to early human era. Methods: We reviewed how the understanding of the aetiogenesis, symptomatology, diagnosis and treatment of gout including myths have evolved and discussed the implications...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2009-10-01
|
| Series: | South African Family Practice |
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/1320 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849329797609553920 |
|---|---|
| author | Olufemi B. Omole Gboyega A. Ogunbanjo |
| author_facet | Olufemi B. Omole Gboyega A. Ogunbanjo |
| author_sort | Olufemi B. Omole |
| collection | DOAJ |
| description | Background: Few diseases that confront the 21st century clinician have documented history which dates back to early human era.
Methods: We reviewed how the understanding of the aetiogenesis, symptomatology, diagnosis and treatment of gout including myths have evolved and discussed the implications thereof.
Results: Gout has been recognized as a clinical entity before 2000BC with Hippocrates describing the five aphorism of gout. Between the 1st and the 6th century AD, the role of genetics and the association of gout with an indulgent lifestyle and tophi were described. Hemodactyl (a source of colchicines) was also first identified during this period. “Gout” was coined from the Latin word “Gutta” in the 13th century and the microscopy of uric acid crystals and gout symptomatology were the focus of investigations between the 17th and 18th centuries. Several drug treatments were developed between the 19th and 20th centuries including salicylates, probenecid and allopurinol. Gout as a risk factor for metabolic syndrome, NIDDM and cardiovascular disease is a challenge for the 20th century and the future.
Conclusion: The understanding of gout has evolved with human development but the challenges for the future will include how to deal with the associated cardiovascular co-morbidities. |
| format | Article |
| id | doaj-art-5423d68eb4bd4cb794d4b130885b7eab |
| institution | Kabale University |
| issn | 2078-6190 2078-6204 |
| language | English |
| publishDate | 2009-10-01 |
| publisher | AOSIS |
| record_format | Article |
| series | South African Family Practice |
| spelling | doaj-art-5423d68eb4bd4cb794d4b130885b7eab2025-08-20T03:47:10ZengAOSISSouth African Family Practice2078-61902078-62042009-10-0151510.1080/20786204.2009.108738901091The evolution of gout (an old disease of lifestyle)Olufemi B. Omole0Gboyega A. Ogunbanjo1Department of Family Medicine, University of WitwatersrandDepartment of Family Medicine and Primary Health Care, University of LimpopoBackground: Few diseases that confront the 21st century clinician have documented history which dates back to early human era. Methods: We reviewed how the understanding of the aetiogenesis, symptomatology, diagnosis and treatment of gout including myths have evolved and discussed the implications thereof. Results: Gout has been recognized as a clinical entity before 2000BC with Hippocrates describing the five aphorism of gout. Between the 1st and the 6th century AD, the role of genetics and the association of gout with an indulgent lifestyle and tophi were described. Hemodactyl (a source of colchicines) was also first identified during this period. “Gout” was coined from the Latin word “Gutta” in the 13th century and the microscopy of uric acid crystals and gout symptomatology were the focus of investigations between the 17th and 18th centuries. Several drug treatments were developed between the 19th and 20th centuries including salicylates, probenecid and allopurinol. Gout as a risk factor for metabolic syndrome, NIDDM and cardiovascular disease is a challenge for the 20th century and the future. Conclusion: The understanding of gout has evolved with human development but the challenges for the future will include how to deal with the associated cardiovascular co-morbidities.https://safpj.co.za/index.php/safpj/article/view/1320gouthistorylifestyleuric acid |
| spellingShingle | Olufemi B. Omole Gboyega A. Ogunbanjo The evolution of gout (an old disease of lifestyle) South African Family Practice gout history lifestyle uric acid |
| title | The evolution of gout (an old disease of lifestyle) |
| title_full | The evolution of gout (an old disease of lifestyle) |
| title_fullStr | The evolution of gout (an old disease of lifestyle) |
| title_full_unstemmed | The evolution of gout (an old disease of lifestyle) |
| title_short | The evolution of gout (an old disease of lifestyle) |
| title_sort | evolution of gout an old disease of lifestyle |
| topic | gout history lifestyle uric acid |
| url | https://safpj.co.za/index.php/safpj/article/view/1320 |
| work_keys_str_mv | AT olufemibomole theevolutionofgoutanolddiseaseoflifestyle AT gboyegaaogunbanjo theevolutionofgoutanolddiseaseoflifestyle AT olufemibomole evolutionofgoutanolddiseaseoflifestyle AT gboyegaaogunbanjo evolutionofgoutanolddiseaseoflifestyle |